Bionaut: Revolutionizing CNS drug delivery. Bionaut is a global biotechnology and drug delivery company dedicated to pioneering innovative solutions for brain-targeted therapies. Conventional drug delivery methods (infusion, intra-thecal) grapple with the blood-brain barrier, yielding low brain concentration, limited efficacy, and systemic side effects. Surgical options (ventricular catheters, CED) are invasive and have restricted reach. Our cutting-edge minimally invasive micro-robotic precision CNS drug delivery platform enables the accurate, safe, and effective administration of treatments to challenging brain & spine regions for a diverse range of therapeutics (small molecules, biologics, ASOs, AAVs, Gene Tx, Radiotherapy). Backed by robust pre-clinical safety data and poised for upcoming 2024 clinical trials, Bionaut seeks to explore collaboration with pharma companies.